This inventor holds 1 USPTO granted patent. Top assignee: The Catholic University of Korea. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Hyun Woo Cho: Innovator in Gamma Delta T Cell Research
Introduction
Hyun Woo Cho is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of immunology, particularly in the development of methods for growing gamma delta T cells. His innovative approach has the potential to advance therapeutic applications in cancer treatment.
Latest Patents
Hyun Woo Cho holds a patent for a novel feeder cell and a method for growing gamma delta T cells. The patent, titled "Feeder cell and method for growing gamma delta T cells by using same," describes a technique that allows for the in vitro growth of a large number of gamma delta T cells with high purity. This method utilizes a feeder cell that incorporates costimulatory molecules and a low concentration of IL-2. The innovation enables differentiation into central memory cells when stimulated, enhancing the cytolytic activity against tumor cells.
Career Highlights
Hyun Woo Cho is affiliated with the Catholic University of Korea Industry-Academic Cooperation Foundation. His work focuses on bridging the gap between academic research and practical applications in the medical field. His dedication to advancing cell therapy has positioned him as a key figure in his area of expertise.
Collaborations
Hyun Woo Cho collaborates with notable colleagues, including Tai Gyu Kim and Hyun Jung Sohn. These partnerships enhance the research efforts and contribute to the development of innovative solutions in immunotherapy.
Conclusion
Hyun Woo Cho's contributions to gamma delta T cell research exemplify the impact of innovative thinking in the medical field. His patent and collaborative efforts highlight the importance of advancing therapeutic techniques for cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile